MedPlus Q2: revenue up 21% while net profit barely moves
Indian pharmacy chain MedPlus reported 21.3% revenue growth in Q2 FY27, with net profit up just 0.9%. Source: TradingView.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
MedPlus Health Services Ltd said on Tuesday, October 27, that its net profit for the second quarter of FY27 rose 0.9% year on year to 56 crore rupees, from 55.5 crore a year earlier. Revenue climbed 21.3% to 2,037 crore rupees. EBITDA grew 14.1% to 170 crore, but the EBITDA margin slipped to 8.4% from 8.9%.
The gross margin fell 110 basis points year on year to 25.1%, though it improved 60 basis points from the previous quarter. The company added 166 stores on a net basis, bringing its total to 5,642 as of September 30, 2026. Stores open for more than 12 months posted store-level ROCE of 72%. Operating cash flow for the quarter came to 37 crore rupees. According to TradingView, the shares closed on the BSE at 624 rupees, up 2.51%.
why it matters
The numbers show top-line growth outpacing profit: thinner gross margins and fast network expansion are weighing on earnings. For investors tracking Indian healthcare retail, the quarter suggests scale is not yet translating into profit at the same pace.
market impact
MedPlus shares: strong revenue against weaker margins gives a mixed signal
- MedPlus Health Services shares mixed — revenue and store growth support the stock, while margin compression and flat profit hold it back
tags
instruments
sources
- MedPlus Q2 Results: Net profit flat as revenue surges 21%; store-level ROCE at 72% — TradingView, 27 October 2026 at 13:40 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗